| SC 13G/A | 2021-01-29 | BlackRock Inc. | Epizyme, Inc. | 7,911,028 | 7.8% | EDGAR |
| SC 13G/A | 2020-10-09 | PRIMECAP MANAGEMENT CO/CA/ | Epizyme, Inc. | 15,068,427 | 14.8% | EDGAR |
| SC 13D/A | 2020-02-21 | RPI Finance Trust | Epizyme, Inc. | 11,666,667 | 11.4% | EDGAR |
| SC 13G/A | 2020-02-14 | Redmile Group, LLC | Epizyme, Inc. | 9,137,373 | 9.9% | EDGAR |
| SC 13G/A | 2020-02-14 | Palo Alto Investors LP | Epizyme, Inc. | 6,145,945 | 6.8% | EDGAR |
| SC 13G/A | 2020-02-12 | PRIMECAP MANAGEMENT CO/CA/ | Epizyme, Inc. | 13,659,104 | 15.0% | EDGAR |
| SC 13G | 2020-02-11 | VANGUARD GROUP INC | Epizyme, Inc. | 6,806,333 | 7.5% | EDGAR |
| SC 13G/A | 2020-02-10 | Celgene European Investment Co LLC | Epizyme, Inc. | 3,607 | - | EDGAR |
| SC 13G/A | 2020-02-05 | BlackRock Inc. | Epizyme, Inc. | 6,929,696 | 7.6% | EDGAR |
| SC 13D | 2019-11-18 | RPI Finance Trust | Epizyme, Inc. | 9,166,667 | 9.1% | EDGAR |
| SC 13D/A | 2019-07-08 | NEW ENTERPRISE ASSOCIATES 13 LP | Epizyme, Inc. | - | - | EDGAR |
| SC 13G/A | 2019-02-14 | KLEINER PERKINS CAUFIELD & BYERS XIII, LLC | Epizyme, Inc. | 3,838,167 | 4.8% | EDGAR |
| SC 13G/A | 2019-02-14 | Palo Alto Investors LP | Epizyme, Inc. | 6,935,074 | 8.8% | EDGAR |
| SC 13G | 2019-02-14 | Redmile Group, LLC | Epizyme, Inc. | 6,637,278 | 8.4% | EDGAR |
| SC 13G/A | 2019-02-13 | FMR LLC | Epizyme, Inc. | 3,472,377 | 4.4% | EDGAR |
| SC 13G/A | 2019-02-11 | VANGUARD GROUP INC | Epizyme, Inc. | 3,643,104 | 4.6% | EDGAR |
| SC 13G/A | 2019-02-08 | PRIMECAP MANAGEMENT CO/CA/ | Epizyme, Inc. | 9,556,527 | 12.1% | EDGAR |
| SC 13G/A | 2019-02-04 | BlackRock Inc. | Epizyme, Inc. | 5,193,287 | 6.6% | EDGAR |
| SC 13G/A | 2018-10-10 | FMR LLC | Epizyme, Inc. | 3,666,203 | 5.3% | EDGAR |
| SC 13G/A | 2018-02-27 | PRIMECAP MANAGEMENT CO/CA/ | Epizyme, Inc. | 8,275,327 | 11.9% | EDGAR |